ArticleNeurosurgery2026
Impact of Subventricular Zone Invasion on Preoperative Cognitive Decline in Patients with Diffuse Glioma.
Article in Neurosurgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
BACKGROUND AND
objectivesTo assess the impact of subventricular zone (SVZ) invasion on neurocognitive dysfunction in patients with diffuse glioma.
methodsWe analyzed neuropsychological assessments of 129 patients with World Health Organization grade 2-4 treatment-naive diffuse glioma (2017-2023). Univariable and multivariable regression analyses were used to identify factors associated with cognitive dysfunction. A nomogram was developed to predict cognitive impairment probabilities, and the model's predictive accuracy was assessed using area under the curve. Statistical analyses were performed using IBM SPSS 20 and R. A P -value of <.05 was considered significant.
resultsSVZ invasion (SVZ+) was present in 64 patients and was linked to more cognitive deficits compared with SVZ- (65 patients). In low-grade gliomas, SVZ+ increased risks of language and visual learning impairments, whereas in high-grade tumors, it heightened language and auditory learning vulnerabilities. In right hemispheric tumors, SVZ+ conferred worse global cognition, executive, and language function; in left hemispheric tumors, SVZ+ increased risks of language and auditory learning impairments. Frontal horn of SVZ+ was related to working memory decline, and body part of SVZ+ was related to emotional deficits. SVZ+ was an independent predictor of cognitive decline alongside age, T2 volume, and World Health Organization grade. A final model and nomogram composed of age, T2 volume, and SVZ invasion achieved moderate predictive accuracy (area under the curve 0.749) for cognitive dysfunction.
conclusionSVZ invasion affects preoperative neurocognitive function independent of tumor laterality and grade, with distinct SVZ subregions associated with specific cognitive impairments. These findings highlight the need for precise tumor mapping considering the SVZ to evaluate neurocognitive outcomes and consider preventive or rehabilitative interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.